The disclosure generally relates to compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various dis
-
Page/Page column 253
(2013/04/13)
New antiarrhythmic agents. Piperazine guanidine derivatives
-
Pascal,Pinhas,Laure,Dumez,Poizot
p. 81 - 85
(2007/10/02)
More Articles about upstream products of 30954-78-0